{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Androgen Deprivation Therapy Could Protect Men Against COVID-19
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about an epidemiological study suggesting a relationship between androgen deprivation therapy (ADT) and COVID-19Learning Objectives
After completing this continuing education activity you will be able to:
- Distinguish the characteristics of androgen deprivation therapy (ADT) and of COVID-19 that lend support to the hypothesis that ADT might improve outcomes in men with COVID-19.
- Synthesize the study findings and their implications for treatment and research.
Disclosures
The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity, have disclosed that they have no fi nancial relationships with, or financial interests in, any commercial companies relevant to this educational activity.
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0720
Published: July 2020
Expires: 9/6/2024
Sources:
Oncology Times
Required Passing Score: 8/10 (80%)
Specialties:
Oncology